The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ProCAID: A phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone (DP) chemotherapy for metastatic castration resistant prostate cancer (mCRPC).
 
Simon J. Crabb
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Janssen; Novartis; Sanofi
 
Alison J. Birtle
Research Funding - Astellas Pharma; Janssen; Sanofi
 
Karen Martin
No Relationships to Disclose
 
Nichola Downs
No Relationships to Disclose
 
Megan Bowers
No Relationships to Disclose
 
Ian Ratcliffe
No Relationships to Disclose
 
Mary Ellis
No Relationships to Disclose
 
Gareth Griffiths
No Relationships to Disclose
 
Stuart Thompson
No Relationships to Disclose
 
Vincent Khoo
No Relationships to Disclose
 
Robert J. Jones
Research Funding - AstraZeneca